This study found that N-cadherin, vimentin, and Twist were downregulated in all three glioblastoma cell lines (U87MG, LNZ308, and LN229) with the increase in the metformin dose, indicating that metformin could reduce glioblastoma migration and invasion by inhibiting EMT. The gene discussed is CDH2; the disease is glioblastoma.